Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Other Non Operating Income: 2012-2024

Historic Other Non Operating Income for Tg Therapeutics (TGTX) over the last 8 years, with Dec 2024 value amounting to $7.7 million.

  • Tg Therapeutics' Other Non Operating Income rose 22.47% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year increase of 98.86%. This contributed to the annual value of $7.7 million for FY2024, which is 52.52% up from last year.
  • Per Tg Therapeutics' latest filing, its Other Non Operating Income stood at $7.7 million for FY2024, which was up 52.52% from $5.0 million recorded in FY2023.
  • Over the past 5 years, Tg Therapeutics' Other Non Operating Income peaked at $7.7 million during FY2024, and registered a low of $2.3 million during FY2021.
  • Over the past 3 years, Tg Therapeutics' median Other Non Operating Income value was $5.0 million (recorded in 2023), while the average stood at $5.8 million.
  • Data for Tg Therapeutics' Other Non Operating Income shows a peak YoY surged of 103.51% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Tg Therapeutics' Other Non Operating Income stood at $2.3 million in 2021, then spiked by 103.51% to $4.7 million in 2022, then climbed by 7.43% to $5.0 million in 2023, then spiked by 52.52% to $7.7 million in 2024.